6QC vs 9SO: Side-by-Side Comparison
Compare TOWA PHARMA. CO. (6QC) and Solasia Pharma K.K (9SO) side by side: market cap EUR 994.40M vs EUR 30.03M. Financials, growth and model signals on Bullrun.
| Metric | 6QC | 9SO |
|---|---|---|
| Company | TOWA PHARMA. CO. | Solasia Pharma K.K |
| Country / Exchange | Japan · F | Japan · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | EUR 994.40M | EUR 30.03M |
| P/E ratio | 34.8 | — |
| Dividend yield | 2.25% | — |
| Valuation model | 28.7% overvalued | — |
| Revenue (FY2025) | EUR 259.59B | EUR 429.00M |
| Revenue growth YoY | +13.9% | +35.8% |
| Net income | EUR 18.99B | EUR -876.00M |
| Gross margin | 36.5% | 48.3% |
| Diluted EPS | 385.71 | — |